WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007003670) FIBROSIS MARKERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/003670    International Application No.:    PCT/ES2006/000367
Publication Date: 11.01.2007 International Filing Date: 22.06.2006
IPC:
G01N 33/68 (2006.01)
Applicants: PROYECTO DE BIOMEDICINA CIMA, S.L. [ES/ES]; C/ Etxesakan 28, Oficina 5 (Pta. Baja), E-31180 Cizur Mayor (Navarra) (ES) (For All Designated States Except US).
CORRALES IZQUIERDO, Fernando [ES/ES]; (ES) (For US Only).
SESMA AGUIRRE, Laura [ES/ES]; (ES) (For US Only).
FERNANDEZ IRIGOYEN, Joaquín [ES/ES]; (ES) (For US Only).
PRIETO VALTUEÑA, Jesús [ES/ES]; (ES) (For US Only).
AVILA ZARAGOZA, Matías [ES/ES]; (ES) (For US Only)
Inventors: CORRALES IZQUIERDO, Fernando; (ES).
SESMA AGUIRRE, Laura; (ES).
FERNANDEZ IRIGOYEN, Joaquín; (ES).
PRIETO VALTUEÑA, Jesús; (ES).
AVILA ZARAGOZA, Matías; (ES)
Agent: UNGRÍA LÓPEZ, Javier; Avda. Ramón y Cajal, 78, E-28043 Madrid (ES)
Priority Data:
P200501611 01.07.2005 ES
Title (EN) FIBROSIS MARKERS
(ES) MARCADORES DE FIBROSIS
(FR) MARQUEURS DE LA FIBROSE
Abstract: front page image
(EN)The invention relates to the use of a combination of at least two markers that are selected from among Uromodulin, MAC2BP, AGP1 and Cathepsin A, for the in vitro detection of fibrotic alterations. In addition, the invention relates to a kit for determining the levels of said markers in a biological sample.
(ES)La presente invención se refiere al uso de una combinación de al menos dos marcadores seleccionados entre Uromodulina, MAC2BP, AGPl, y Catepsina A, para la detección in vitro de alteraciones fibróticas. Además, la presente invención se refiere a un kit para determinar los niveles de dichos marcadores en una muestra biológica.
(FR)La présente invention concerne l'utilisation d'une combinaison d'au moins deux marqueurs sélectionnés parmi l'uromoduline, MAC2BP, AGPI et la cathepsine A, à des fins de détection in vitro d'altérations fibreuses. La présente invention concerne également une trousse permettant de déterminer la concentration de marqueurs dans un prélèvement biologique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)